Loading…
Lobbying Spend
—
Filings
5
Firms Hired
1
Active Period
2007–2008
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Enhancing Drug Safety and Innovation Act of 2007
2008 · second_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1561
Health Freedom Protection Act
2008 · second_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2117
Pharmaceutical Market Access and Drug Safety Act of 2007
2008 · second_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: H.R. 380
Food and Drug Administration Safety Act of 2007
2008 · second_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: H.R. 788
Pharmaceutical Market Access Act of 2007
2008 · second_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: S. 251
Food and Drug Administration Safety Act of 2007
2008 · second_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: S. 468
Enhancing Drug Safety and Innovation Act of 2007
2008 · second_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: S. 484
Enhancing Drug Safety and Innovation Act of 2007
2008 · first_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1561
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2117
Pharmaceutical Market Access and Drug Safety Act of 2007
2008 · first_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: H.R. 380
Food and Drug Administration Safety Act of 2007
2008 · first_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: H.R. 788
Pharmaceutical Market Access Act of 2007
2008 · first_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: S. 251
Food and Drug Administration Safety Act of 2007
2008 · first_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: S. 468
Enhancing Drug Safety and Innovation Act of 2007
2008 · first_quarter · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007
Client expense: — · Firm income: $20,000
Matched citations: S. 484
Enhancing Drug Safety and Innovation Act of 2007
2007 · year_end · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2900 Food and Drug Administration Amendments of 2007
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1561
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2900 Food and Drug Administration Amendments of 2007
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2117
Food and Drug Administration Amendments Act of 2007
2007 · year_end · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2900 Food and Drug Administration Amendments of 2007
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2900
Pharmaceutical Market Access and Drug Safety Act of 2007
2007 · year_end · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2900 Food and Drug Administration Amendments of 2007
Client expense: — · Firm income: $30,000
Matched citations: H.R. 380
Food and Drug Administration Safety Act of 2007
2007 · year_end · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2900 Food and Drug Administration Amendments of 2007
Client expense: — · Firm income: $30,000
Matched citations: H.R. 788
Pharmaceutical Market Access Act of 2007
2007 · year_end · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2900 Food and Drug Administration Amendments of 2007
Client expense: — · Firm income: $30,000
Matched citations: S. 251
Food and Drug Administration Safety Act of 2007
2007 · year_end · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2900 Food and Drug Administration Amendments of 2007
Client expense: — · Firm income: $30,000
Matched citations: S. 468
Enhancing Drug Safety and Innovation Act of 2007
2007 · year_end · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2900 Food and Drug Administration Amendments of 2007
Client expense: — · Firm income: $30,000
Matched citations: S. 484
Pharmaceutical Market Access and Drug Safety Act of 2007
2007 · mid_year · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007
Client expense: — · Firm income: $30,000
Matched citations: H.R. 380
Pharmaceutical Market Access Act of 2007
2007 · mid_year · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007
Client expense: — · Firm income: $30,000
Matched citations: S. 251
Food and Drug Administration Safety Act of 2007
2007 · mid_year · Firm: DAVIDSON & COMPANY
S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007
Client expense: — · Firm income: $30,000
Matched citations: S. 468
Source: Senate LDA